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Abstract
Background: In England and Wales, the Department of Health introduced a primary prevention programme, NHS
Health Checks, to provide screening for cardiovascular risk amongst people aged 40-74. The aim of this programme
is to offer treatment and advice to those identified with an increased risk of cardiovascular diseases (CVD).
The North East of England has some of the highest rates of CVD in the UK and prevention is therefore a priority.
NHS Tees funded this programme of work under the local branding of Healthy Heart Checks (HHC). These were
initially implemented principally through GP practices from October 2008 but, in order to mitigate the possibility
that some hard to reach communities would be reluctant to engage with some primary care settings, plans were
also developed to deliver the programme through workplace settings and through community pharmacies. This
paper reports specifically on the findings from the evaluation in respect of the setting up of HHCs in community
pharmacies and aims to offer some lessons for other service settings where this option is seen as a way of
providing low threshold services which will minimise inequalities in intervention uptake.
Methods: In assessing the community pharmacy component of HHCs, a selection of staff having direct
involvement in the process was invited to take part in the evaluation. Interviews were carried out with
representatives from community pharmacy, staff members from the commissioning Primary Care Trusts and with
Local Pharmaceutical Committee members.
Results: Evaluation and analysis identified challenges which should be anticipated and addressed in initiating HHC
in community pharmacies. These have been categorised into four main themes for discussion in this paper: (1)
establishing and maintaining pharmacy Healthy Heart Checks, (2) overcoming IT barriers, (3) developing confident,
competent staff and (4) ensuring volume and through flow in pharmacy.
Conclusions: Delivering NHS health checks through community pharmacies can be a complex process, requiring
meticulous planning, and may incur higher than expected costs. Findings from our evaluation provide insight into
possible barriers to setting up services in pharmacies which may help other commissioning bodies when
considering community pharmacy as a location for primary prevention interventions in future.
Background
The most common cause of death and premature disabil-
ity worldwide is cardiovascular disease (CVD) [1,2], and
in the UK diseases of this type cause high level of chronic
illness which affect the quality of life of many and result
in costly demands in terms of providing health services at
every level. The impact of the disease is disproportio-
nately felt amongst more disadvantaged populations, not
least because modifiable risk factors such as diet, smok-
ing and physical activity significantly contribute to the
prevalence of CVD [3].
Reducing this illness burden has therefore become a
major goal of the UK government, and in England and
Wales, the Department of Health has introduced a
national programme to screen individuals aged 40-74 for
early warning signs of cardiovascular risk. This pro-
gramme was branded as NHS Health Checks (NHS HC).
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bidity and mortality associated with CVD [3]. In the Tees
Valley Healthy Heart Checks (HHC) were established
ahead of the national guidance, in response to recom-
mendations made locally by the Health Inequalities
National Support Team.
There is ample evidence, however, that such well meant,
population-level interventions may actually contribute to
widening health inequalities [4]. This intervention, for
instance, is primarily offered through GP practices, but stu-
dies have shown that some groups of the public rarely visit
their GP [5] and it was therefore a prime aim of the HHC
programme to avoid making the inequalities worse by
e x c l u d i n gg r o u p sw h i c hm a yb em o r ev u l n e r a b l ea n da t
risk anyway. From the start of planning the programme in
Tees (April 2008), easy access to checks in workplaces and
community pharmacy settings was seen as a valuable addi-
tion to assessments offered in general practitioner surgeries.
This paper reports on the phase of initiation of the
programme through community pharmacies as part of
the strategic approach to deliver HHCs in a variety of
community settings.
Delivery of vascular risk assessments in community phar-
macy has been widely encouraged as a means of reaching
out to people who may be more reluctant to access screen-
ing services at other venues [6,7]. In recent years the face
of community pharmacy has shifted from one charac-
terised predominantly by small single-handed pharmacies
that dealt mainly with issuing prescribed medications, to
one which has seen the rise of the multiple chain pharmacy
which can offer many additional services [8,9]. It has there-
fore been argued that pharmacy is now ideally placed to
offer public health interventions, screening services and to
deliver basic lifestyle advice in the hope of widening access
to health services [8,10-12]. In a large scale survey of the
general public, Krska and Morecroft [13] report that the
general public tend to access pharmacy for specific reasons,
primarily to have prescriptions dispensed and to purchase
medicines and non medical items. They use the service less
frequently to seek out health advice A market research sur-
vey carried out by Readers Digest [14] indicate that people
in relatively more deprived social classes, however, use
community pharmacies more frequently than their affluent
counterparts for health information and advice. In part this
may be attributed to longer opening hours and access
without appointment, but possibly also because pharmacies
are regarded as less dauntingly professional in their
response to clients [6].
Despite the government’se n d o r s e m e n tf o rt h i s
approach, a recent review of the changing role of com-
munity pharmacy in the NHS noted the limited evidence
for effectiveness and value for money of services such as
screening in pharmacies [9]. Patel [15] also cautioned
about the use of non NHS providers to deliver CVD
assessments, and called for the development of robust
data systems that could handle the transfer of data
between the non NHS provider and primary care provi-
ders without duplicating results.
In a small scale, real world trial delivering targeted vas-
cular assessments through community pharmacies in Bir-
mingham, Horgan et al showed that they had achieved
particular success in engaging individuals from minority
ethnic groups, [10] suggesting that pharmacy may indeed
be useful in reducing some health inequalities. Horgan
et al went on to report that men - a segment of the popu-
lation renowned for not attending services in GP prac-
tices [16] - had engaged with the programme delivered
through community pharmacy [6]. This suggests that in
the real world pharmacy may offer a better chance of
engaging certain segments of the population. However,
there is conflicting evidence which suggests that the gen-
eral public do not always view pharmacy as a place to
receive lifestyle advice or screening, owing to concerns
about lack of capacity amongst pharmacy staff and confi-
dentiality [13]. It is thus far from clear whether commu-
nity pharmacy offers the panacea ‘low threshold’ service
that commissioners had hoped for, in the sense of pro-
viding easy access services at times to suit the patient,
without an appointment and provided by staff who are
intrinsically more accessible and approachable.
The evaluation of the initiation of community pharmacy
based screening in the Tees Valley allows us to share
insights which may help other commissioning bodies both
to assess realistically what is involved in setting up such
assessments, and to model appropriately the likely cost per
assessment. The complexity of population primary preven-
tion and the emphasis on this as a future means of achiev-
ing health gain without increasing inequality suggests that
our findings may provide lessons beyond the system we
studied.
Methods
The study described in this paper was part of an overall
evaluation which used a Theory of Change [17] frame-
work, entailing a process of continual feedback between
the researchers and the organisations being evaluated to
provide a clear model of the logic of the programme, to
shape the direction of programme change and provide
evidence for suggested modifications. In this respect the
commissioning organisation was provided with constant
updates about findings from the evaluation. Staff in the
delivery and implementation arms of the intervention
kept the research team abreast of all changes made to
the initial programme protocol.
Participants
Ten Primary Care Trust (PCT) members of staff who
had direct professional involvement in setting up HHCs
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interviews. Staff included the Director of Public Health,
project manager, clinical lead, public health nurses,
pharmacy advisor (medicines management), community
services manager, a professional executive committee
member and the IT database developer.
All nine pharmacies that were hoping to take part in
the pilot phase of the HHC programme were contacted
and invited to take part in the evaluation. Eight pharma-
cists agreed to be interviewed. Pharmacy customers
were not included within this evaluation.
Two representatives from the Local Pharmaceutical
Committee (LPC) also took part in the evaluation.
Data collection
Each participant was contacted by letter and provided
with written information about the aims of the project
and what would be required of them should they agree
to participate.
One-to-one interviews were undertaken with each parti-
cipant. These interviews followed a semi structured format
and centred around the setting up of the HHC programme
within pharmacies. PCT members of staff and pharmacists
were interviewed about the selection and recruitment of
pharmacies into the HHC programme; clinical governance
and health and safety issues; development of the Service
Level Agreement (SLA); pharmacy accommodation; train-
ing provision and IT development, data collection and
transfer. LPC members were asked about the role of the
LPC in developing the SLA. Anonymity and confidentiality
were assured and each participant was encouraged to be
frank and open about their experiences of setting up the
HHCs in community pharmacy. Each interview lasted
between 20 and 60 minutes and was, with the consent of
the participant, digitally recorded. Interviews were subse-
quently transcribed verbatim. All names, places of work
and other identifying features were removed from the text
of the transcriptions to avoid participants being identified.
Pharmacists were interviewed at two time points, once
before and once after they went live delivering the HHC
assessments.
Data analysis
Transcriptions of each interview were read and indepen-
dently scrutinised by two members of the research team.
Data were then analysed and coded using a thematic con-
tent analysis [18] framework. Each analyst read all tran-
scripts several times to familiarise him/herself with the
issues raised and developed a coding framework to estab-
lish themes. Initial codes were identified independently
and all data supporting the codes were highlighted in the
transcripts. These initial codes were then grouped
together to form themes which were then corroborated
between analysts. Once agreement had been achieved
between analysts, these themes were written into a narra-
tive form to provide an accurate illustration of the theme
using quotations taken directly from the transcripts.
The School of Health and Social Care Ethics Commit-
tee at Teesside University scrutinised and approved this
study protocol.
Results
Eight pharmacies signed up to the Service Level Agree-
m e n ta n dt o o kp a r ti nt h ep i l o tp h a s eo fH H Cd e l i v e r y
across the Tees Valley. Of these eight pharmacies six
were small pharmacist led businesses that were located
out in community settings and two were large multiples
one of which was situated in a supermarket chain the
other in a purpose built ‘health village’. Pharmacies were
required to provide CVD risk assessment to individuals,
calculate possible CVD risk over the next ten years and
signpost to medical intervention or offer lifestyle advice
as appropriate. In this section we provide an overview of
findings from the evaluation, grouped together under the
main emergent themes; establishing and managing phar-
macy Healthy Heart Checks, overcoming IT barriers,
developing confident, competent staff, ensuring volume
and through flow in pharmacy.
Establishing and managing pharmacy Healthy Heart
Checks
It was decided in the Tees Valley that HHCs would be
delivered through a selection of community pharmacies
as a method to engage hard to reach populations that
would not necessarily access this type of service through
a GP practice. Guidance from the Department of Health
suggested that PCTs look outside of GP practices as sites
to deliver the NHS HC programme and that they should
consider community based venues. PCT staff felt, at the
time, there was sufficient evidence from around the UK
to support the inclusion of community pharmacy as a
place to offer the HHC programme.
The Department of Health had said they wanted us to
look at other providers [other than GP practices], and com-
munity pharmacies, they thought, would be a good venue.
There had been projects around the country like the big
one in Birmingham that was very successful, fantastic
results, doing CVD assessments. (PCT staff member)
It was assumed that pharmacies had become trusted
sources of information within the community, through deli-
vering services such as smoking cessation. Pharmacies also
have a wide customer group which tends to access their
services on a regular basis, again making them potentially
ideal locations to situate a service like the HHC programme
and providing a low threshold, non threatening service that
might be less likely to increase health inequalities:
From my experience of working in a deprived area, as
a health visitor, people do access pharmacies like they
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macy, and from being in [names pharmacy] that is very
evident. It’s ‘Hi Tom. I need this, I need that. What can
I do about this? Can I try that?’ They [the pharmacists]
know their population very well. (PCT staff member)
Accordingly, a plan was made to involve community
pharmacies as a major partner in cardiovascular risk
assessment, and initial preparations were made for mar-
keting to the public the availability of checks in pharma-
cies. It was largely taken for granted that the initiation of
checks in willing pharmacies would be straightforward
and quick. In the event, however, implementation proved
to be very complex, and the initiation of assessments (even
in a small pilot group of pharmacies) was delayed by over
a year.
Pharmacists were eager at first to be involved in deli-
vering extra services, as the HHCs were potentially both
a method of generating extra revenue and bringing more
people into their stores:
We do focus on the services, we do a lot of morning after
pills. We have started doing the flu and cervical cancer
vaccinations. So in this store we like doing the services,
b e c a u s ei tb r i n g sp e o p l ei n t ot h es t o r e(Pharmacy 1
representative)
As the Tees service began to roll forward, information
began to be fed back, through the national NHS HC
network, from other areas in the country that had been
delivering checks through pharmacies. Some commis-
sioners had begun to withdraw services from pharma-
cies because low levels of uptake had made them non
viable.
[In other PCT areas] it has not worked for them. For
instance in [names area], they had 30 pharmacies set up
and they have taken the equipment off half of them
because there was no activity. (PCT staff member)
During the initial set up for delivering HHCs through
the Tees pharmacies many changes took place within the
PCT. Swine flu hit the UK and required rapid and
immediate response. Staff who had been involved with the
early stages of managing the HHC programme were not
able to see it through to completion, which also impacted
on the HHC programme.
The PCT aimed to recruit pharmacies against set inclu-
sion criteria that related to making sure pharmacies played
a major part in addressing issues of disadvantage. How-
ever, after recruitment of pharmacies began, it soon
became apparent that not all pharmacy accommodation
was of a sufficient standard to deliver the HHCs. Each
pharmacy was required to have in place a private consulta-
tion room with secure access to the Internet and hand
washing facilities, but there was huge variability between
pharmacies in the appropriateness of the accommodation:
Some [spaces offered for checks], are brilliant, whereas
some were like an old broom cupboard. I would have
liked to have visited them myself beforehand (PCT staff
member)
Much work went into developing a Service Level
Agreement for the HHC, this took over a year to develop.
Many obstacles became apparent during this time, which
had not been anticipated. It became clear that payments
needed to be handled differently to those for GP prac-
tices, as pharmacies pay VAT on all services they deliver.
This took time to resolve and required much input from
organisations outside of the PCT:
We had to go away and create prices that would actu-
ally work; a set up fee, an annual fee and then a small
fee for actually doing the service (LPC member)
Additional resources had to be assigned to the phar-
macy roll out of the programme when it became appar-
ent that, unlike staff working in other settings such as
GP practices, pharmacy staff did not have the relevant
vaccinations to enable them to deal with blood and bod-
ily fluids. To this end all staff delivering the HHCs had
to receive Hepatitis B vaccinations, which had an addi-
tional impact on the budget as clarified by a PCT staff
member:
We have actually paid a lot of the pharmacies to have
Hepatitis B vaccinations which is a requirement for nurses
and GPs who deal with bodily fluids. We have actually
paid for that out of our CVD budget (PCT staff member)
Overcoming IT barriers
It became clear very quickly that pharmacies did not have
a sufficiently secure Internet connection to allow them to
transfer patient identifiable data to the NHS server which
held the HHC database. To overcome this problem phar-
macies were required to upgrade their Internet connec-
tion and were issued with a special ‘RAS’ token for extra
security. This RAS token generated random number
combinations which increased security when accessing
the NHS server, it worked in a similar way to a card
reader for Internet banking. The requirement for
increased Internet security and the use of such tokens
posed much more of a problem for some of the larger
chain pharmacies than the smaller independent ones.
Larger chains found that their company policies dictated
that they could not have open access to the Internet,
which was one of the requirements to enable connection
to the PCT server. For this reason some of the larger
chain pharmacies were unable to take part in this roll out
of HHCs in pharmacy. For those pharmacies that were
able to connect freely to the Internet and met all of the
security requirements, they were able to trial the database
they would be using, and felt that it was user friendly:
It is nice that the computer system leads you through
step-by-step (Pharmacy 7 representative)
Once the system went live however, it was evident
that there were some technical errors which affected the
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promptly by the PCT: however it did affect pharmacists’
confidence in the system.
Developing confident, competent staff
From the PCT’s point of view the training needs of phar-
macy staff were much greater than initially envisaged. It
had originally been expected that pharmacists would deli-
ver the service to customers themselves, but it soon
became clear that this was impractical due to the fact
that many pharmacists are sole traders and have a variety
of other daily commitments. It was then agreed that
pharmacy assistants could carry out the initial assessment
which involved; taking anthropometric measurements
from the patients, medical history, blood pressure and
blood samples. This meant that the pharmacist would
only be involved at the end of the consultation, delivering
t h ef i n a lr i s ks c o r ea n dg i v i n gl i f e s t y l ea d v i c et ot h e
patient. This increased the training load significantly in
order to make sure that pharmacy assistants were compe-
tent to carry out the assessment:
The pharmacists are highly skilled and highly trained.
The people they have working for them, who are normally
dispensing assistants, haven’t got the background in care
knowledge or expertise. It wasn’t like a GP surgery where
you have Healthcare Assistants and Practice Nurses who
on a day to day basis take blood pressures, take pulses,
take blood and give advice on health (PCT staff member)
To address this issue a training package was developed
and delivered by the PCTs and it was well received by
pharmacy staff. Due to the nature of pharmacy businesses
it soon became apparent that training would need to take
place out of office hours. The PCT took a flexible
approach to this, which was appreciated by pharmacy
staff as their needs had been taken into consideration.
There was however quite a time lag between pharmacy
staff being trained and then beginning to deliver the ser-
vice to members of the public, and this then necessitated
further refresher training from the PCT. Once trained,
pharmacy assistants felt that delivering the HHC service
was a good opportunity for staff development and were
pleased with the increased responsibility that went with
it:
One of our counter staff...said ‘I never thought I would
be doing this!’ She’sq u i t ee x c i t e da n di t ’sah u g ej u m p
from their present role (PCT staff member).
In pharmacies, the HHC programme ‘went live’ in Jan-
uary 2010. As part of the agreement between PCT and
pharmacy, all pharmacy staff were required to be trained
and signed off, by the PCT, as competent to deliver the
assessments. At the end of the service evaluation (August
2010), not all staff had achieved this. This was due to two
main reasons. Uptake of the screening opportunity by the
p u b l i ch a db e e nv e r yl o w ,m e a n i n gt h ep h a r m a c ys t a f f
had not had the opportunity to deliver many assessments.
Pharmacy staff had also required a lot more training than
initially anticipated and, even after being given this sup-
port, lacked confidence in delivering the new service:
One girl has already been signed off. The other lady is
just waiting to be signed off. She is still a bit nervous
about getting bloods from people (Pharmacy 6
representative)
Ensuring volume and through flow in pharmacy
Across the seven pharmacies that began to deliver the
HHC programme, uptake has been low. Between January
and September 2010, 204 assessments had taken place in
pharmacies across the Tees Valley. During the same per-
iod, 2082 assessments had been completed in workplaces
and 16,050 in GP practices across Tees. The number of
completed assessments varied greatly from pharmacy to
pharmacy, ranging from 9 assessments in one pharmacy
to 49 in another. All pharmacies felt disappointed with
this level of uptake, despite the PCT advertising the service
within each pharmacy and through adverts in the local
press. Pharmacy staff also advertised the service to patients
entering their stores to try and raise awareness and
increase uptake of the service themselves but with very lit-
tle effect. Pharmacists tried to give reasons why uptake
had been low despite efforts to raise awareness of the ser-
v i c et h e yw e r eo f f e r i n g .S o m ef e l tt h a ti tm a yh a v eb e e n
due to their geographic locations and low foot-fall in store:
Id o n ’t know if it’s our location, that there isn’t enough
people coming through (Pharmacy 4 representative)
This view was also held by some PCT staff, who added
that some of the pharmacists delivering HHCs were very
close to GP practices that were also delivering the HHC,
introducing competition between providers:
Some [pharmacies] are really struggling because they
are out of town and in locations close to GP practices -
which is where the pharmacies get a lot of their business
from (PCT staff member)
This view was held by pharmacists too. They felt phar-
macies and GP practices were in direct competition, trying
to entice a finite number of patients into what was, essen-
tially, the same service:
Actually there’s another problem, capturing the people.
Everyone is out to capture them...it’s very hard if you see
someone coming in and say, ‘Oh! You could be a candi-
date’, and they say, ‘The surgery has approached me and
I’m going there’ (Pharmacy 5 representative)
Discussion
This study gave us important insights into initiating pri-
mary prevention services in community pharmacy and
some of the obstacles which, in future, might be avoided.
To aid rollout of similar interventions in community
pharmacy we would recommend that commissioning
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Valley. Unforeseen problems resulted in a much delayed
service in community pharmacies. The optimistic
assumption that it would be simple to carry out HHCs in
pharmacies was soon proved wrong. Critical phases in
development were too dependent on individuals and con-
tingency plans were not made in the event of sickness or
other absence. The priority applied to NHS Health
Checks, and the additional work entailed, needed to be
made explicit to all of those responsible for operationalis-
ing the policy across the PCT directorates.
Because of the complexities involved in setting up this
service the true cost per assessment was not anticipated.
In advance of implementation the uptake of HHCs in
pharmacy could only be estimated, as no intervention of
this kind had been delivered through this setting before.
Whether the price for the contract should include indirect
as well as direct costs and VAT needed to be resolved at
an early stage. Ancillary costs, most importantly those for
pharmacy staff training, consumables, nursing support and
IT support, are an essential part of the calculation and in
the case of the Tees PCTs were much higher than origin-
ally expected. Moreover, the low throughput of patients
could make the set up costs of this type of service uneco-
nomical in the long term.
Commissioners will rightly expect pharmacies delivering
HHCs to meet NHS standards for criteria such as privacy
of consulting space, availability of hand washing facilities,
secure Internet connections for patient data transfer and
appropriate application of health and safety procedures,
e.g. for disposal of sharps and handling of blood. These
criteria are not always met in pharmacies. To establish
equity of access for assessments substantial additional
investment may be required in pharmacies with poorer
facilities to bring them up to expected standards. PCTs
need to balance cost, coverage and equity in rolling out
pharmacy based health checks.
The SLA that is negotiated with pharmacies must
recognise the important differences between general
practice and pharmacy provision. In particular, general
practice teams, which rely routinely on health care assis-
tants and practice nurses to carry out such procedures,
have clinical experience which is not generally mirrored
in pharmacies. In a pharmacy team the pharmacist is
likely to be the only person with the skills to undertake
clinical assessment and communicate the level of risk
assessed from the HHC. It is unrealistic to expect the
pharmacist him/herself personally to deliver the 30-40
minute health check, especially if an open access policy
(i.e. no appointment needed) is being followed. Therefore
extra training costs should be considered when consider-
ing pharmacy as a venue to deliver this kind of service.
Commissioners need to consider carefully issues such
as the VAT payable by pharmacies (but not general
practices), and whether costs for the full service (includ-
ing equipment, disposables, waste disposal and staff
i m m u n i s a t i o n )i si n c l u d e di nt h ed e t a i l e ds e r v i c e
specification.
The question of whether targets for activity should be
set is contentious: a minimum level of activity seems
necessary to maintain competence and efficient use of dis-
posables, but may be incompatible with the aspiration to
make checks available in all pharmacies. The calculation
of cost per case, and decisions about value for money, are
strongly influenced by both the service specification and
HHC activity in individual pharmacies
Many pharmacies do not have the full access to the NHS
network which is required for the efficient and secure
transfer of information between pharmacy, PCT and gen-
eral practice, even if a common database and a system of
common codes has been agreed. Confidentiality standards
and the degree of access permitted to staff within a phar-
macy team are important issues.
In establishing HHCs in Tees pharmacies achieving con-
nectivity with the NHS, staff IT training and continuing
support proved time consuming and costly. In some cases,
the data security practised by national pharmacy chains
impeded the loading of software onto pharmacy systems.
Once the system was live there were some issues with cal-
culations of risk score which impacted on pharmacists’
trust in the system. Thorough piloting of IT systems is
essential in these situations.
The extent of training required to bring members of
pharmacy teams to the level where they could competently
and confidently carry out the HHC process was greatly
underestimated. This was made worse by the length of
time between initial selection and the activation of the ser-
vice. Time is required not only for initial training, which is
itself a problem given the constraints on releasing both
pharmacists and team members during a six-day working
week, but there is a need for continuing support to assure
clinical governance and quality. The training received by
pharmacy teams evaluated very positively, and there was
clear evidence that staff felt empowered by the opportu-
nity to add to their role by delivering a clinical service.
Conclusions
It may be said that all the issues that were identified
could have been anticipated. However, being an early
adopter of change in a complex intervention entails risks
which can be avoided by others as experience accumu-
lates, and our purpose in providing this paper is to indi-
cate areas which deserve early consideration by
commissioning bodies. We are aware, from anecdotal
evidence, that PCTs in other regions have had similar
experiences. We believe that considering the lessons
learned in this report will improve the efficiency, increase
the timeliness and may well benefit patients if it enhances
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